Lieff Cabraser partner Katherine Lubin Benson will speak at the American Bar Association’s Class Actions National (Virtual) Institute on Wednesday, October 14th, 2020 at 12:00 pm ET. Katherine will be featured on the panel “Building the Best Firewall. Ethical Issues In Settlement Negotiations and Approval of Class Action Settlements.”
Using Rule 23 as a guide, panelists will examine how to ethically and efficiently settle class actions—discussing their timing, scope, blow provisions, and attempts to restrict plaintiffs’ counsel’s right to practice. Panelists will also discuss attorneys’ fees, including when plaintiffs may request them and how best to calculate them.
The exceptional list of panelists includes:
Honorable Jon S. Tigar, U.S. District Court for the Northern District of California
Professor Josh P. Davis, University of San Francisco School of Law
Katherine Lubin Benson, Lieff Cabraser Heimann & Bernstein LLP
John Roberti, Allen & Overy LLP
Melissa H. Maxman, Cohen & Gresser LLP (Moderator)
About Katherine Lubin Benson
A partner in Lieff Cabraser’s San Francisco office, Katherine Lubin Benson specializes in securities and derivative suits and antitrust class actions. She was one of the firm’s attorneys heading the shareholder derivative action against Wells Fargo’s current and former officers and directors arising from the bank’s massive illicit sales practices scandal. Katherine was a key member of Lieff Cabraser team representing Co-Lead Plaintiff Fire and Police Pension Association of Colorado in the action, which settled for a $240 million cash payment and corporate governance reforms in late 2018. The settlement received final approval in April 2020, and represents the largest insurer-funded derivative settlement in history. Lieff Cabraser’s work on the case was recognized by the American Antitrust Institute, which honored the firm with the 2020 Outstanding Private Practice Antitrust Achievement award. Katherine was awarded AAI’s Outstanding Antitrust Litigation Achievement by a Young Lawyer award for her contributions to the case.
Katherine served as Class Counsel representing a class of hospitals, third-party payors, and uninsured persons in 29 states and the District of Columbia in an antitrust action against defendants Momenta Pharmaceuticals, Inc. and Sandoz Inc. for their alleged monopolization of enoxaparin, the generic version of the anti-coagulant blood clotting drug Lovenox. The case resulted in a nationwide settlement totaling $120 million, making it the second largest indirect purchaser antitrust pharmaceutical settlement fund in history.
Katherine was recently named as one of six lawyer representatives to the Ninth Circuit Judicial Counsel for the 2020-2023 term, and currently serves on the Board of Directors of the Northern District Practice Program, which provides continuing legal education programing for judges and practitioners in the district. She also serves on the Board of Directors of the East Bay Community Law Center, a non-profit affiliated with Berkeley Law providing free legal services to low-income communities.